Molecule-kinase interaction map.
Buolamwini
John K
JK
Kamath
Shantaram
S
D000818:Animals; D019295:Computational Biology / Q000379:methods*; D015195:Drug Design; D066246:ErbB Receptors / Q000378:metabolism; D014644:Genetic Variation; D006801:Humans; D008832:Microchemistry / Q000379:methods; D009154:Mutation; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology; D011381:Programming Languages; D025941:Protein Interaction Mapping / Q000379:methods*; D011799:Quinazolines / Q000494:pharmacology; D012984:Software; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism
D004364:Pharmaceutical Preparations; D010880:Piperidines; D011799:Quinazolines; D066246:ErbB Receptors; D040301:Vascular Endothelial Growth Factor Receptor-2; C452423:vandetanib